机构地区:[1]南通市海门区人民医院检验科,江苏南通226100
出 处:《转化医学杂志》2024年第9期1424-1428,共5页Translational Medicine Journal
摘 要:目的探讨C反应蛋白/前清蛋白比值(CRP/PAB)与社区获得性肺炎(CAP)患者病情的关系及对疾病转归的预测效能。方法选取2020年1月至2022年12月南通市海门区人民医院收治的126例CAP患者,根据CURB-65评分评估患者病情,并分入轻度组(95例),重度组(31例)。采用酶联免疫吸附法检测患者血清C反应蛋白、前清蛋白水平,并计算CRP/PAB。记录所有患者发病30 d的疾病转归情况。采用Pearson相关分析探讨CAP患者CRP/PAB与CURB-65评分的相关性。采用受试者工作特征(ROC)曲线评估CRP/PAB对CAP30d疾病转归的预测价值。采用多因素Logistic逐步回归分析探讨CAP患者疾病转归的影响因素。结果轻度组患者血清CRP、CRP/PAB水平低于重度组,PAB水平高于重度组患者(均P<0.05);CAP患者血清CRP、CRP/PAB与CURB-65评分均呈正相关,血清PAB水平与CURB-65评分成负相关(均P<0.05);存活组血清CRP,CRP/PAB水平明显低于死亡组,PAB水平高于死亡组(均P<0.05);ROC结果显示血清CRP、PAB及CRP/PAB预测CAP患者疾病转归的最佳截断值分别为128.65mg/L、91.43mg/L、2.03。CRP/PAB比值预测CAP患者疾病转归的曲线下面积(AUC)(95%CI)为0.915(0.877~0.963)。死亡组患者急性生理学及慢性健康状况Ⅱ(APACHEⅡ)评分、肺炎严重指数(PSI)评分高于存活组(P<0.05);多因素Logistic逐步回归分析显示,PSI评分(OR=4.162,95%CI:1.703~10.173)、APACHEⅡ评分(OR=3.854,95%CI:1.692~8.778)、CRP/PAB≥2.03(OR=5.244,95%CI:2.071~13.277)是CAP患者疾病转归的影响因素(P<0.05)。结论CRP/PAB比值与CAP患者病情及疾病转归密切相关,其对CAP患者临床转归具有一定的预测效能。Objective To explore the correlation between C-reactive protein/prealbumin ratio(CRP/PAB)and disease of cases with community-acquired pneumonia(CAP)and the predictive efficacy of the disease outcome.Methods A total of 126 patients with CAP were selected.The patients'conditions were evaluated according to CURB-65 score,and they were divided into mild group(n=95)and severe group(n=31).The levels of serum C-reactive protein and prealbumin were detected by enzyme-linked immunosorbent assay,and CRP/PAB were calculated.The disease outcomes of all patients were recorded 30 days after disease.The correlation between CRP/PAB and CURB-65 scores were evaluated by Pearson correlation.ROC was used to evaluate the predictive value of C-reactive protein/prealbumin ratio in 30d disease outcome of CAP.The influencing factors of disease outcome in cases with CAP were explored by multivariate Logistic stepwise regression.Results Serum CRP and CRP/PAB levels in mild group were lower than those in severe group,and PAB levels were higher compared with severe group(all P<0.05).Serum CRP and CRP/PAB in CAP patients were positively correlated with CURB-65 score,and serum PAB levels were negatively correlated with CURB-65 score(all P<0.05).Serum CRP and CRP/PAB levels in survival group were significantly lower than those in death group,and PAB levels were higher than those in death group(all P<0.05).ROC results showed that the best cut-off values of serum CRP,PAB and CRP/PAB for predicting disease outcome in CAP patients were 128.65 mg/L,91.43 mg/L and 2.03,respectively.The AUC(95%CI)of CRP/PAB ratio for predicting disease outcome in CAP patients was 0.915(0.877~0.963).APACHEⅡscores and PSI scores in death group were higher compared with survival group(P<0.05).PSI score(OR=4.162,95%CI:1.703-10.173),APACHEⅡscore(OR=3.854,95%CI:1.692-8.778),CRP/PAB≥2.03(OR=5.244,95%CI:2.071-13.277)were the influential factors for disease outcome in patients with CAP(P<0.05).Conclusion CRP/PAB ratio is closely related to the disease condition and disea
关 键 词:C反应蛋白/前清蛋白比值 社区获得性肺炎 病情 疾病转归:预测效能
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...